Correlation Between Selective Insurance and Catalyst Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Selective Insurance and Catalyst Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Selective Insurance and Catalyst Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Selective Insurance Group and Catalyst Pharmaceuticals, you can compare the effects of market volatilities on Selective Insurance and Catalyst Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Selective Insurance with a short position of Catalyst Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Selective Insurance and Catalyst Pharmaceuticals.
Diversification Opportunities for Selective Insurance and Catalyst Pharmaceuticals
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Selective and Catalyst is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Selective Insurance Group and Catalyst Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalyst Pharmaceuticals and Selective Insurance is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Selective Insurance Group are associated (or correlated) with Catalyst Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalyst Pharmaceuticals has no effect on the direction of Selective Insurance i.e., Selective Insurance and Catalyst Pharmaceuticals go up and down completely randomly.
Pair Corralation between Selective Insurance and Catalyst Pharmaceuticals
Given the investment horizon of 90 days Selective Insurance Group is expected to generate 0.55 times more return on investment than Catalyst Pharmaceuticals. However, Selective Insurance Group is 1.82 times less risky than Catalyst Pharmaceuticals. It trades about -0.29 of its potential returns per unit of risk. Catalyst Pharmaceuticals is currently generating about -0.24 per unit of risk. If you would invest 9,741 in Selective Insurance Group on October 10, 2024 and sell it today you would lose (645.00) from holding Selective Insurance Group or give up 6.62% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Selective Insurance Group vs. Catalyst Pharmaceuticals
Performance |
Timeline |
Selective Insurance |
Catalyst Pharmaceuticals |
Selective Insurance and Catalyst Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Selective Insurance and Catalyst Pharmaceuticals
The main advantage of trading using opposite Selective Insurance and Catalyst Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Selective Insurance position performs unexpectedly, Catalyst Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Pharmaceuticals will offset losses from the drop in Catalyst Pharmaceuticals' long position.Selective Insurance vs. Kemper | Selective Insurance vs. Donegal Group B | Selective Insurance vs. Argo Group International | Selective Insurance vs. Global Indemnity PLC |
Catalyst Pharmaceuticals vs. Day One Biopharmaceuticals | Catalyst Pharmaceuticals vs. Terns Pharmaceuticals | Catalyst Pharmaceuticals vs. X4 Pharmaceuticals | Catalyst Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |